Abstract
Coronary artery diseases (CAD), a non-communicable disease, pose a formidable healthcare challenge globally, particularly in India. Therefore, the demand for advanced medical interventions continues to rise. Coronary stents (CS) play a pivotal role in managing CAD. Coronary stents CS are generally available as bare-metal and drug-eluting varieties. This research delves into the landscape of coronary stents approved in India, leveraging data from the official website of the Central Drugs Standard Control Organization (CDSCO), which is the national Regulatory Authority for Medical Devices in India. This study provides critical insights for stakeholders, informing strategies for future research, development, and policy formulation in coronary stent technology in India.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Health Technology and Innovation
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
